● There is considerable variation among cytometry reagents, instruments and analysis approaches used for hematological disease diagnosis and monitoring.
● We previously demonstrated that our approach is adaptable across different instruments for sample level classification model development.
● In this study, we combined three different panels: ClearLLab10C, Euroflow AML/MDS and a UPMC diagnostic panel to demonstrate the feasibility of developing sample and cell level classification models thats instrument and reagent agnostic.